Literature DB >> 25783388

Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome.

Richard Hill1, Alberto Quaglia2, Munther Hussain2, Nedim Hadzic3, Giorgina Mieli-Vergani3, Diego Vergani2, Mark Davenport4.   

Abstract

BACKGROUND: Biliary atresia (BA), a cholangiopathy of unknown etiology is associated with intrahepatic mononuclear cell infiltrate. An abnormal reaction to viral exposure has been hypothesized in some cases. We aimed to investigate the nature of the CD4+ hepatic infiltrate in defined clinical variants of BA by quantification of inflammatory cell components.
METHODS: Liver biopsies of infants obtained at Kasai portoenterostomy (KPE) were stained immunohistochemically using monoclonal antibodies to Tbet, GATA-3, FOXP3 and interleukin (IL) 17, identifying Th-1, Th-2, Tregs and Th-17 cells respectively. T cells were counted with the aid of a graticule. Data are reported as median (range) of cells per high-power-field (×400) and compared using nonparametric statistical tests with P≤0.05 regarded as significant.
RESULTS: Liver biopsies from BA (n=37) and age-matched cholestatic controls (e.g. alpha-1-anti trypsin deficiency, Alagilles syndrome, n=12) were investigated. BA infants were divided into three groups: cytomegalovirus IgM +ve (CMV; n=9); BA splenic malformation (BASM; n=9) and isolated BA (IBA; n=19). All T-cell subsets were present in the portal tracts, with an overrepresentation of Th-1 (P<0.001) and Th-17 (P<0.03), but not Th-2 (P=0.94) or Tregs (P=0.15), compared to controls. Th-1 cells predominated in the CMV group; (18 [7-37] vs. 3 [0-14] [BASM] and vs. 5 [3-23] [IBA]; P<0.01 both), while no subgroup differences were seen for Th-17 cells. The degree of Th-1 cell infiltrate inversely correlated with platelet count (rS=-0.49; P<0.01). Th-17 cells were fewer (6 [2-11] vs. 11 [8-20]; P=0.02) in infants who cleared their jaundice (n=15, <20μmol/L) although this did not translate to improved native liver survival (P=0.17).
CONCLUSIONS: Th-17 cells infiltrate the liver in BA and are associated with a worse surgical outcome; a Th-1 profile predominates in CMV-associated BA.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliary atresia; Inflammatory response; Interleukin-17; T-cells; Tregs

Mesh:

Substances:

Year:  2015        PMID: 25783388     DOI: 10.1016/j.jpedsurg.2015.02.005

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  13 in total

1.  Developmental histology of the portal plate in biliary atresia: observations and implications.

Authors:  Enrico La Pergola; Yoh Zen; Mark Davenport
Journal:  Pediatr Surg Int       Date:  2021-03-01       Impact factor: 1.827

Review 2.  Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?

Authors:  Mark Davenport
Journal:  Pediatr Surg Int       Date:  2017-09-22       Impact factor: 1.827

Review 3.  Liver fibrosis in biliary atresia.

Authors:  Wen-Jun Shen; Gong Chen; Min Wang; Shan Zheng
Journal:  World J Pediatr       Date:  2018-11-21       Impact factor: 2.764

4.  The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia.

Authors:  Celine S Lages; Julia Simmons; Avery Maddox; Keaton Jones; Rebekah Karns; Rachel Sheridan; Shiva Kumar Shanmukhappa; Sujit Mohanty; Matthew Kofron; Pierre Russo; Yui-Hsi Wang; Claire Chougnet; Alexander G Miethke
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425

Review 5.  Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.

Authors:  Kenichi Harada
Journal:  Pediatr Surg Int       Date:  2017-10-16       Impact factor: 1.827

Review 6.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

Review 7.  Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.

Authors:  Christy E Trussoni; Steven P O'Hara; Nicholas F LaRusso
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 11.759

8.  Correlation of Immune Markers With Outcomes in Biliary Atresia Following Intravenous Immunoglobulin Therapy.

Authors:  Sehee Kim; Jeffrey Moore; Estella Alonso; Joseph Bednarek; Jorge A Bezerra; Catherine Goodhue; Saul J Karpen; Kathleen M Loomes; John C Magee; Vicky L Ng; Averell H Sherker; Caroline Smith; Cathie Spino; Veena Venkat; Kasper Wang; Ronald J Sokol; Cara L Mack
Journal:  Hepatol Commun       Date:  2019-03-25

Review 9.  Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy.

Authors:  Athanasios Tyraskis; Christopher Parsons; Mark Davenport
Journal:  Cochrane Database Syst Rev       Date:  2018-05-14

Review 10.  Steroids after the Kasai procedure for biliary atresia: the effect of age at Kasai portoenterostomy.

Authors:  Athanasios Tyraskis; Mark Davenport
Journal:  Pediatr Surg Int       Date:  2015-11-21       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.